Nicolaas AJ Puts1,2, Ericka L Wodka3,4, Ashley D Harris1,2,5,6, Deana Crocetti7, Mark Tommerdahl8, Richard AE Edden1,2, and Stewart H Mostofsky3,7,9
1Radiology and Radiological Science, Johns Hopkins University, Baltimore, MD, United States, 2F.M. Kirby Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, MD, United States, 3Center for Autism and Related Disorders, Kennedy Krieger Institute, Baltimore, MD, United States, 4Psychiatry and behavioral sciences, Johns Hopkins University, Baltimore, MD, United States, 5Alberta Children's Hospital Research Institute, University of Calgary, Calgary, AB, Canada, 6Radiology, University of Calgary, Calgary, AB, Canada, 7Laboratory for Neurocognitive and Imaging Research, Kennedy Krieger Institute, Baltimore, MD, United States, 8Biomedical Engineering, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States, 9Neurology, Johns Hopkins University, Baltimore, MD, United States
Synopsis
Children with Autism often show difficulties processing sensory stimuli, but the underpinnings are poorly understood. Multiple
lines of evidence suggest that GABA, the main inhibitory neurotransmitter in
the brain, plays a role in the pathophysiology of ASD. Here we show reduced GABA levels in children with ASD, which is associated with abnormal performance on vibrotactile tasks related to inhibition. We show that alterations in GABA can contribute to alterations in sensory processing in ASD.Purpose
Autism Spectrum Disorder (ASD) is a developmental
disorder characterized by impairments in social cognition, communication,
and repetitive behaviors
1. In addition, difficulties with sensory stimuli
have been increasingly recognized and are now included as a diagnostic feature
of ASD. Multiple lines of evidence suggest that GABA, the main inhibitory
neurotransmitter in the brain, plays a role in the pathophysiology of ASD (e.g.
2). It is well known that GABA
plays a key role in regulating tactile processing
3-5. However, the link
between GABA and autism-associated impairments in vibrotactile processing
remains unclear. GABA can be measured using edited Magnetic Resonance
Spectroscopy (MRS) and we developed a technique to measure tactile sensitivity
in children objectively, in tasks linked to inhibition
6. In this study, in a large cohort, we aimed to
investigate whether 1) children with ASD have reduced GABA levels, 2) children
with ASD show altered vibrotactile processing, and 3) altered GABA
levels are associated with abnormal tactile processing in ASD.
Methods
Subject and parental
consent were obtained under local IRB approval. Eligibility:
Children with ASD met the DSM-V criteria for ASD, confirmed using the Autism Diagnostic Observation Schedule-Version 2
(ADOS-2). All Typically Developing Children (TDC) were free of criteria for
psychiatric disorders using the Diagnostic Interview for Children and Adolescents.
Data were acquired in 37 children with ASD (10.69 ± 1.4 years,
6F) and 35 TDC (10.09 ± 1.25 years; 8F). Children
had normal IQ. Imaging: GABA-edited MR spectra were acquired from (3 cm)3
voxels over right primary sensorimotor (Fig 1A&B) and occipital cortices using MEGA‑PRESS, on a
3T Philips ‘Achieva’ scanner (Philips Medical Solutions, Best, the Netherlands).
Parameters: TE 68 ms; 14 ms editing pulse at 1.9 (ON) and 7.46 (OFF) ppm; TR
2000ms; 320 transients, 32-channel head coil. A T1w MPRAGE was acquired prior
to MRS acquisition for voxel placement and segmentation (TR = 7.99 ms, TE = 3.76 ms,
Flip angle = 8°). GABA levels were calculated against the
unsuppressed water signal from the same voxel. Data were tissue corrected,
normalized to a cohort (ASD + TDC) voxel average grey and white matter ratios
as described previously
7, and implemented within Gannet
8. Behavioral:
Children performed: 1) Static and Dynamic detection tasks (where the increasing
(dynamic) sub-threshold stimulus is thought to act through feed-forward
inhibition
9); 2) Amplitude discrimination with- and without an
adapting stimulus (linked to lateral inhibition
10); and 3) Frequency discrimination (encoded through
GABAergic inhibition
3,11; FD).
Results
Sensorimotor GABA levels were significantly reduced
in children with ASD compared to TDC (2.20 ± 0.44 i.u. and 2.40 ± 0.25 i.u. respectively,
p = 0.016). There were no group differences in occipital GABA levels. For
children with ASD, sensorimotor GABA levels correlated positively with dynamic
detection threshold, with higher GABA levels indicating a higher detection
threshold (Fig 2A). The difference between a static and dynamic detection
threshold (Figure 2B) were significantly correlated with GABA levels within the
entire cohort (R = 0.39, p < 0.005); this finding was driven by children
with ASD (Fig 2B), such that those with lower GABA levels showed a reduced
effect of sub-threshold stimulation. Amplitude discrimination performance after
single-site adaptation correlated with GABA levels in TDC (R = 0.44, p = 0.019)
but not in ASD (R =-0.21, p = 0.3; Fig 2B) and the effect of adaptation was
absent in ASD. Tactile FD is correlated with GABA in TDC, which has been
previously reported
11 (R = -0.41, p =0.025; Fig 2C); this association
was not observed in ASD.
Discussion
Sensorimotor GABA levels were reduced in children
with ASD compared to TDC, while occipital levels are normal, consistent with
previous work
12. Tactile abnormalities in ASD were consistent with
previous work, and the absence of the effect of either a sub-threshold
stimulus, or an adapting stimulus, in ASD, is consistent with reduced
GABA-mediated inhibition. Our correlative results are consistent with the
prediction for children with ASD; reduced GABA level was associated with
stronger effect of modulating stimuli (sub-threshold and adaptation). Finally,
GABA levels in TDC are correlated with FD, which is consistent with published
findings in healthy adults. While children with ASD do not show differences in
FD performance, they do not show GABA-FD correlation, suggesting that GABA does
not act similarly to TDC in terms of frequency encoding.
Conclusion
Children with ASD show reduced GABA levels, and are
associated with abnormalities in tactile performance. Altered in vivo GABA
levels might contribute to abnormal tactile-information processing in ASD. The GABA
system may be a future and novel target for therapies in ASD.
Acknowledgements
NAJP was funded by an Autism Speaks Translational
Post-doctoral Fellowship. This work was further supported by NIH P41 EB015909
and R21 MH098228 and NIH / NINDS: R01 MH078160; R01
EB016089References
1. Rogers SJ, Ozonoff S. Annotation:
what do we know about sensory dysfunction in autism? A critical review of the
empirical evidence. J Child Psychol Psychiatry 2005;46:1255-1268.
2. Rubenstein JL, Merzenich MM. Model
of autism: increased ratio of excitation/inhibition in key neural systems.
Genes Brain Behav 2003;2:255-267.
3. McLaughlin DF, Juliano SL.
Disruption of layer 4 development alters laminar processing in ferret
somatosensory cortex. Cereb Cortex 2005;15:1791-1803.
4. Juliano SL, Whitsel BL, Tommerdahl
M, Cheema SS. Determinants of patchy metabolic labeling in the somatosensory
cortex of cats: a possible role for intrinsic inhibitory circuitry. J Neurosci
1989;9:1-12.
5. Dykes RW, Landry P, Metherate R,
Hicks TP. Functional role of GABA in cat primary somatosensory cortex: shaping
receptive fields of cortical neurons. J Neurophysiol 1984;52:1066-1093.
6. Puts NA, Edden RA, Wodka EL,
Mostofsky SH, Tommerdahl M. A vibrotactile behavioral battery for investigating
somatosensory processing in children and adults. J Neurosci Methods 2013.
7. Harris AD, Puts NA, Edden RA. Tissue
correction for GABA-edited MRS: Considerations of voxel composition, tissue
segmentation, and tissue relaxations. J Magn Reson Imaging 2015.
8. Edden RA, Puts NA, Harris AD, Barker
PB, Evans CJ. Gannet: A batch-processing tool for the quantitative analysis of
gamma-aminobutyric acid-edited MR spectroscopy spectra. J Magn Reson Imaging
2014;40:1445-1452.
9. Blankenburg F, Taskin B, Ruben J, et
al. Imperceptible stimuli and sensory processing impediment. Science
2003;299:1864.
10. Tommerdahl M, Favorov OV, Whitsel BL.
Dynamic representations of the somatosensory cortex. Neurosci Biobehav Rev
2010;34:160-170.
11. Puts NA, Edden RA, Evans CJ, McGlone
F, McGonigle DJ. Regionally specific human GABA concentration correlates with
tactile discrimination thresholds. J Neurosci
2011;31:16556-16560.
12. Gaetz W, Bloy L, Wang DJ, et al. GABA
estimation in the brains of children on the autism spectrum: Measurement
precision and regional cortical variation. Neuroimage 2013.